Myocardial Revascularization Surgery: One or Two Internal-Thoracic-Artery Grafts?

Myocardial Revascularization SurgeryThe use of both internal thoracic (mammary) arteries for myocardial revascularization surgery might improve long-term outcomes, compared with the use of a single internal thoracic artery.

 

Patients scheduled for myocardial revascularization surgery (only multivessel procedures; combined valve procedures were excluded) were randomized to receive a single internal-thoracic-artery graft (internal thoracic artery for the anterior descending artery, other vessels with grafts from veins or the radial artery) or two internal-thoracic-artery grafts (other vessels with grafts from veins or the radial artery) in 28 cardiac surgical centers in 7 countries.

 

The primary endpoint was all-cause death at 10 years, and the secondary endpoint was a composite of all-cause death, acute myocardial infarction, or stroke. An interim analysis was prespecified at 5 years of follow-up and is reported in this summary.

 

A total of 3102 patients were enrolled; 1554 were randomized to receive a single internal-thoracic-artery graft and 1548 to receive a double internal-thoracic-artery graft.

 

At 5 years of follow-up, the mortality rate was 8.7% for patients in the double internal-thoracic-artery graft group and 8.4% for those in the single internal-thoracic-artery graft group (hazard ratio [HR]: 1.04; 95% confidence interval [CI]: 0.81 to 1.32; p = 0.77). The rate of the composite endpoint of all-cause death, infarction, and stroke was 12.2% vs. 12.7%, respectively (HR: 0.96; 95% CI: 0.79 to 1.17; p = 0.69).

 

Differences were indeed observed regarding the risk of sternal wound infection, which was higher among those receiving a double internal-thoracic-artery graft (3.5% vs. 1.9%; p = 0.005), and the need for sternal reconstruction (1.9% vs. 0.6%; p = 0.002).

 

Conclusion

Among patients undergoing myocardial revascularization surgery, there were no benefits at 5 years for those receiving double internal-thoracic-artery grafts when compared with those in which only the left internal thoracic artery was used. Sternal wound infections and the need for sternal reconstruction were significantly more frequent in patients receiving double internal-thoracic-artery grafts. Ten-year follow-up is ongoing, and benefits are yet to be seen.

 

Original title: Randomized Trial of Bilateral Versus Single Internal-Thoracic-Artery Grafts.

Reference: David P. Taggart et al. N Engl J Med. 2016 Nov 14. [Epub ahead of print].


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...